4002 alpha-helical domain in dehydroquinate synthase-like enzymes
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 35 | 11.7 | 2.99× | q < 0.0001 | |
| Homogeneous metal compounds | 36 | 20.8 | 1.73× | q < 0.0001 | |
| Homogeneous non-metal compounds | 11 | 9.1 | 1.21× | q = 0.54 | |
| Organic oxygen compounds | 7 | 8.4 | 0.83× | q = 0.77 | |
| Organic acids and derivatives | 2 | 6.6 | 0.30× | q = 0.09 | |
| Organoheterocyclic compounds | 0 | 6.5 | 0 | q = 4.5e-3 | |
| Mixed metal/non-metal compounds | 1 | 0.9 | 1.12× | not tested | |
| Benzenoids | 2 | 3.1 | 0.65× | not tested | |
| Lipids and lipid-like molecules | 1 | 4.7 | 0.21× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB14128 | NAD | Nadide | 87 |
| DB02592 | CRB | Carbaphosphonate | 18 |
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 14 |
| DB02338 | NDP | NADPH | 13 |
| DB00157 | NAI | NADH | 9 |
| DB16833 | ADP | Adenosine disphosphate | 6 |
| DB00145 | GLY | Glycine | 4 |
| DB02319 | NZQ | 5,6-dihydroxy-NADP | 4 |
| DB04326 | 13P | Dihydroxyacetone phosphate | 3 |
| DB00142 | GLU | Glutamic acid | 2 |
| DB02363 | ATR | 2'-Monophosphoadenosine-5'-Diphosphate | 2 |
| DB04349 | PGO | (S)-propane-1,2-diol | 2 |
| DB11326 | BO3 | Boric acid | 2 |
| DB04160 | PPV | Pyrophosphoric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| ZNmetal | ZINC ION | 117 |
| NAD | NICOTINAMIDE-ADENINE-DINUCLEOTIDE | 93 |
| FEmetal | FE (III) ION | 41 |
| FE2metal | FE (II) ION | 32 |
| CRB | [1R-(1ALPHA,3BETA,4ALPHA,5BETA)]-5-(PHOSPHONOMETHYL)-1,3,4-TRIHYDROXYCYCLOHEXANE-1-CARBOXYLIC ACID | 18 |
| CL | CHLORIDE ION | 17 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 14 |
| APR | ADENOSINE-5-DIPHOSPHORIBOSE | 13 |
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 13 |
| MGmetal | MAGNESIUM ION | 12 |
| NImetal | NICKEL (II) ION | 11 |
| Kmetal | POTASSIUM ION | 10 |
| COmetal | COBALT (II) ION | 8 |
| NAI | 1,4-DIHYDRONICOTINAMIDE ADENINE DINUCLEOTIDE | 8 |
| ADP | ADENOSINE-5'-DIPHOSPHATE | 6 |
| MNmetal | MANGANESE (II) ION | 5 |
| NAmetal | SODIUM ION | 5 |
| 13P | 1,3-DIHYDROXYACETONEPHOSPHATE | 4 |
| 7LH | (1R,3R,4S,5R)-3-[3-[3,4-bis(oxidanyl)phenyl]propanoyloxy]-1,4,5-tris(oxidanyl)cyclohexane-1-carboxylic acid | 4 |
| E9I | 2-(3,4-dimethoxyphenyl)ethanamide | 4 |